Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
AARP: Supreme Court Rejects Drugmakers’ Challenge to Medicare Price Negotiations
Their “denial of these petitions brings an end to these six companies’ efforts to dismantle the Medicare Negotiation program,” says Michael Lieberman, counsel for Patients For Affordable Drugs at Fairmark Partners LLP. “Six of the largest pharmaceutical companies in the world, represented by some of the largest law firms in the world, raised a wide […]
News and Reports
Healthcare Finance: Supreme Court declines to hear drugmakers' challenge to price negotiations
Negotiated prices are projected to save 9 million people on Medicare $1.5 billion in out-of-pocket costs, while saving taxpayers $6 billion in 2026 alone, according to Patients For Affordable Drugs.
News and Reports
Epoch Times: Supreme Court Rejects Pharma Challenge to Medicare Price Negotiations
“They raised a variety of arguments challenging the program as a whole,” said Michael Lieberman, attorney at Fairmark Partners LLP, who had filed amicus briefs concerning the lawsuits. The drug makers based their arguments on the First Amendment, the Fifth Amendment’s takings clause, the Eighth Amendment’s prohibition on excessive fines, and due process arguments, Lieberman […]
News and Reports
POLITICO Healthcare PM: SCOTUS sinks pharma’s Medicare negotiation fight
Michael Lieberman, an attorney at Fairmark Partners who worked on the amicus brief for the advocacy group Patients For Affordable Drugs, said it is the end of the line for the six cases. “There are four other cases still pending in lower courts, some of them raising the same issues,” Lieberman said at a press […]
News and Reports
POLITICO: SCOTUS denies pharma challenge to Medicare negotiations
Michael Lieberman, an attorney at Fairmark Partners who worked on the amicus brief for the advocacy group Patients For Affordable Drugs, said it is the end of the line for the six cases. “There are four other cases still pending in lower courts, some of them raising the same issues,” Lieberman said at a press […]
Press Releases
WASHINGTON, D.C. — Following the Supreme Court’s decision this morning to decline petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program, Patients For Affordable Drugs and Public Citizen held a press briefing with a patient advocate and legal expert to discuss the implications for patients and the […]
Press Releases
The 2022 Prescription Drug Law Is Delivering Lasting Reductions in Prescription Drug Costs
WASHINGTON, D.C. — As debate continues around new proposals to lower prescription drug prices for Americans, one thing is clear: the 2022 prescription drug law is already helping to lower costs for millions of patients across the country. “The facts speak for themselves,” said Merith Basey, CEO of Patients For Affordable Drugs. “The Medicare drug price reforms are […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs has reached a major milestone: more than 40,000 vetted patient stories are now on our interactive map, documenting the real-world harm caused by high drug prices. There are stories from every state and every congressional district in the country and the map allows users to explore stories by disease, ZIP code, and more, offering […]